Page last updated: 2024-10-24

chlorambucil and Gait Disorders, Animal

chlorambucil has been researched along with Gait Disorders, Animal in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wootton, F1
Glanemann, B1
Langley-Hobbs, S1
Breheny, C1
Fowlie, S1
Whitworth, F1
Silvestrini, P1
Threlfall, A1
Sorrell, S1
Black, V1

Other Studies

1 other study available for chlorambucil and Gait Disorders, Animal

ArticleYear
Feline non-erosive immune-mediated polyarthritis: a multicentre, retrospective study of 20 cases (2009-2020).
    Journal of feline medicine and surgery, 2022, Volume: 24, Issue:10

    Topics: Animals; Arthritis; Cat Diseases; Cats; Chlorambucil; Cyclosporine; Female; Fever; Immunosuppressive

2022